Abstract
Prolactin-secreting tumors are the most common hormone-secreting pituitary tumors in women and may be the most common hormone-secreting tumors in men as well. It is only within the last five years, with the advent of sensitive radioimmunoassays for prolactin, that the often subtle and varied clinical presentations of these tumors have become apparent. Women with prolactin-secreting tumors (also called prolactinomas) usually present with amenorrhea or galactorrhea, or both, in association with a modestly elevated serum prolactin level in the 50–200 ng/ml range. Plain skull X-rays are often normal, and abnormalities such as focal erosion or enlargement of the sella turcica are detectable only with pleuridirectional tomography. In women with galactorrhea and amenorrhea, the incidence of verified pituitary adenomas has been reported to be as high as 30–50%1,2 (Chapter 4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Nader, K. Mashiter, F.H. Doyle, and F.G. Joplin, Galactorrhea, hyperprolactinemia, and pituitary tumors in the female, Clin. Endocrinol. 5:245, 1976.
D.L. Kleinberg, G.L. Noel, and A.G. Frantz, Galactorrhea: A study of 235 cases, including 48 with pituitary tumors, N. Engl. J. Med. 296:589, 1977.
S.A. Fine and L.A. Frohman, Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors, J. Clin. Invest. 61:973, 1978.
P.J. Snyder, L.S. Jacobs, M.M. Robello, F.S.H. Sterling, R.N. Shore, R.D. Utiger, and W.H. Daughaday, Diagnostic value of thyrotropin-releasing hormone in pituitary and hypothalamic disease, Ann. Intern. Med. 81:751, 1974.
K.D. Post, B.J. Biller, L.S. Adelman, M.E. Molitch, S.M. Wolpert, and S. Reichlin, Results of transsphenoidal adenomectomy in women with galactorrhea—amenorrhea, J. Am. Med. Assoc. 242:158, 1979.
R. Landgraf, A. Weissmann, R. Horl, and M.M.C. Landgraf-Leurs, Is prolactin a diabetogenic hormone?, Diabetologia 11:357, 1975.
R.C. Moehlig, Pituitary tumor associated with gynecomastia, Endocrinology 15:529, 1929.
E.P. McCullagh, J.G. Alivisatos, and C.A. Schaffenburg, Pituitary tumor with gynecomastia and lactation—a case report, J. Clin. Endocrinol. Metab. 16:397, 1956.
I.A. Forsyth, G.M. Besser, C.R.W. Edwards, L. Francis, and R.P. Myres, Plasma prolactin activity in inappropriate lactation, Br. Med. J. 3:225, 1971.
J. Racodot, E. Vila-Porcile, and F. Peillon, Adénomes hypophysares a cellules a prolactine: Etude structurale et ultrastructurale; corrélations anatomocliniques, Ann. Endocrinol. (Paris) 32:298, 1971.
J.E. Finn and L.A. Mount, Galactorrhea in males with tumors in the region of the pituitary gland, J. Neurosurg. 35:723, 1971.
R. Volpe, D. Killinger, C. Bird, A.F. Clark, and H. Friesen, Idiopathic galactorrhea and mild hypogonadism in a young adult male, J. Clin. Endocrinol. Metab. 35:684, 1972.
G.M. Besser, L. Parke, C.R.W. Edwards, I.A. Forsyth, and A.S. McNeilly, Galactorrhea: Successful treatment with reduction of plasma prolactin levels by bromergocryptine, Br. Med. J. 3:669, 1972.
R.M. Boyar and L. Hellman, Syndrome of benign nodular adrenal hyperplasia associated with feminization and hyperprolactinemia, Ann. Intern. Med. 80:389, 1974.
M.O. Thorner, A.S. McNeilly, C. Hagan, and G.M. Besser, Long-term treatment of galactorrhea and hypogonadism with bromocriptine, Br. Med. J. 2:419, 1974.
A.D. Rogal and S.W. Rosen, Prolactin of apparent large molecular size: The major immunoactive prolactin component in plasma of a patient with a pituitary tumor, J. Clin. Endocrinol. Metab. 38:714, 1974.
E.A. Zimmerman, R. Defendini, and A.G. Frantz, Prolactin and growth hormone in patients with pituitary adenomas; a correlative study of hormone in tumor and plasma by im-munoperoxidase technique and radioimmunoassay, J. Clin. Endocrinol. Metab. 38:577, 1974.
D.F. Child, S. Nades, K. Mashifer, M. Kjeld, L. Banks, and T.R. Fraser, Prolactin studies in “functionless” pituitary tumors, Br. Med. J. 1:604, 1975.
W.B. Malarkey and J.C. Johnson, Pituitary tumors and hyperprolactinemia, Arch. Intern. Med. 136:40, 1976.
W.G. Schroffner, Prolactin-secreting pituitary tumor in early adolescence, Arch. Intern. Med. 136:1164, 1976.
Q.L. Van Meter, F.J. Garcia, J.W. Hayes, and C.B. Wilson, Galactorrhea in a 12 year old boy with a chromophobe adenoma, J. Pediatr. 90:756, 1977.
M.P. Koenig, K. Zuppinger, and B. Liechti, Hyperprolactinemia as a cause of delayed puberty: Successful treatment with bromocriptine, J. Clin. Endocrinol. Metab. 45:825, 1977.
J.L. Antunes, E.M. Housepian, A.G. Frantz, D.A. Holub, R.M. Hui, P.W. Carmel, and D.O. Quest, Prolactin-secreting pituitary tumors, Ann. Neurol. 2:148, 1977.
T.J. McKenna, A.D. Glick, C.A. Cobb, and L.S. Jacobs, Galactorrhea and hypogonadism associated with a radiologically-inapparent prolactin-secreting pituitary tumor, Acta. Endocrinol 87:225, 1978.
H.E. Carlson, G.A. Levine, N.J. Goldberg, and J.M. Hershman, Hyperprolactinemia in multiple endocrine adenomatosis, type I, Arch. Intern. Med. 138:1807, 1978.
R.Y. Osamura, K. Watanabe, A. Teramoto, K. Hirakawa, N. Kawano, and S. Morii, Male prolactin secreting pituitary adenomas in humans studies by peroxidase-labelled antibody method, Acta. Endocrinol. 88:643, 1978.
M. Nagulesparen, V. Ang, and J.S. Jenkins, Bromocriptine treatment of males with pituitary tumours, hyperprolactinemia, and hypogonadism, Clin. Endocrinol. 9:73, 1978.
S. Franks, H.S. Jacobs, N. Martin, and J.D.N. Nabarro, Hyperprolactinemia and impotence, Clin. Endocrinol. 8:277, 1978.
J.N. Carter, J.E. Tyson, G. Tolis, S. Van Vliet, C. Faiman, and H.G. Friesen, Prolactin-secreting tumors and hypogonadism in 22 men, N. Engl. J. Med. 299:847, 1978.
A.M. McGregor, M.F. Scanlon, K. Hall, D.B. Cook, and R. Hall, Reduction in size of a pituitary tumor by bromocriptine therapy, N. Engl. J. Med. 300:291, 1979.
C.S. Nicoll, Physiological actions of prolactin, in: Handbook of Physiology, Section 7: Endocrinology, Vol. IV (R.O. Greep and E.B. Astwood, eds.), pp. 253–292, American Physiological Society, Washington, D.C. 1974.
S. Franks, J.D.N. Nabarro, and H.S. Jacobs, Prevalence and presentation of hyperprolactinemia in patients with “functionless” pituitary tumors, Lancet 1:778, 1977.
R.W. Turkington, Serum prolactin levels in patients with gynecomastia, J. Clin. Endocrinol. 34:62, 1972.
A.G. Frantz, D.L. Kleinberg, and G.L. Noel, Studies on prolactin in man, Recent Prog. Horm. Res. 28:527, 1972.
M.T. Buckman and G.T. Peake, Abnormal regulation of prolactin secretion in patients with gynecomastia, Clin. Res. 22:162A, 1974.
P. Fossati, G. Strauch, and J. Tourniare, Etude de l’activité de la bromocriptine dans les états d’hyperprolactinemie, Nouv. Presse Med. 5:1687, 1976.
C. Jaffiol, M. Rubin, A. Orsetti, and J. Mirouze, Le. hormones gonadorropes de la prolactine au cours des gynecomasties, Ann. Endocrinol. (Paris) 37:469, 1976.
A.G. Frantz, Prolactin, N. Engl. J. Med. 298:201, 1978.
R. Goodman, B. Biller, A.C. Moses, M. Molitch, Z. Feldman, and K. Post, Restoration of normal prolactin secretory dynamics after surgical cure of prolactinoma is evidence against underlying hypothalamic dysregulation, Abstracts of The Endocrine Society, 61st Annual Meeting, June 13–15, 1979, p. 159.
M.O. Thorner, G.M. Besser, C. Hagen, and A.S. McNeilly, The relationship between prolactin and gonadotrophins: Effects of clomiphene administration in normal men, J. Endocrinol. 63:43, 1974.
B. Ambrosi, R. Elli, M. Gaggini, M. Rondena, and G. Faglia, Prolactin-secreting tumors and hypogonadism in men, N. Engl. J. Med. 300:563, 1979.
A. Bartke, Effects of prolactin on spermatogenesis in hypophysectomized mice, J. Endocrinol. 49:311, 1971.
A. Bartke, Effects of prolactin and luteinizing hormone on the cholesterol stores in the mouse testes, J. Endocrinol. 49:317, 1971.
N. Musto, A.A. Hafiez, and A. Bartke, Prolactin increases 17β-hydroxysteroid dehydrogenase activity in the testes, Endocrinology 91:1106, 1972.
A.A. Hafiez, C.W. Lloyd, and A. Bartke, The role of prolactin in the regulation of testis function: The effects of prolactin and luteinizing hormone on the plasma levels of testosterone and androstenedione in hypophysectomized rats, J. Endocrinol. 52:327, 1972.
C. Aragona and H.G. Friesen, Specific prolactin binding sites in the prostate and testes of cats, Endocrinology 97:677, 1975.
F.J. Bex and A. Bartke, Testicular LH binding in the hamster: Modification by photoperiod and prolactin, Endocrinology 100:1223, 1977.
C. Aragona, H.G. Bohnet, and H.G. Friesen, Localization of prolactin binding in prostate and testis: The role of serum prolactin concentration on the testicular LH receptor, Acta Endocrinol. 84:402, 1977.
V.S. Fang, S. Refetoff, and R.L. Rosenfield, Hypogonadism induced by a transplantable, pro-lactin-producing tumor in male rats: Hormonal and morphological studies, Endocrinology 95:991, 1974.
A. Bartke, M.S. Smith, S.D. Michael, F.G. Peron, and S. Dalterio, Effects of experimentally-induced chronic hyperprolactinemia on testosterone and gonadotropin levels in male rats and mice, Endocrinology 100:182, 1977.
S.J. Winters and D.L. Loriaux, Suppression of plasma luteinizing hormone by prolactin in the male rat, Endocrinology 102:864, 1978.
R.T. Rubin, P.R. Gouin, A. Lubin, R.E. Poland, and K.M. Pirke, Nocturnal increase of plasma testosterone in men: Relation to gonadotropins and prolactin, J. Clin. Endocrinol. Metab. 40:1027, 1975.
R.T. Rubin, R.E. Poland, and B.B. Tower, Prolactin-related testosterone secretion in normal adult men, J. Clin. Endocrinol. Metab. 42:112, 1976.
R.T. Rubin, R.E. Poland, J.R. Sowers, and J.M. Hershman, Influence of methyl-TRH-induced prolactin increase on serum testosterone levels in normal adult men, J. Clin. Endocrinol. Metab. 46:830, 1978.
R.T. Rubin, R.E. Poland, I. Sobel, B.B. Tower, and W.D. Odell, Effects of prolactin and prolactin plus luteinizing hormone on plasma testosterone levels in normal adult men, J. Clin. Endocrinol. Metab. 47:447, 1978.
B. Ambrosi, P. Travaglini, P. Beck-Peccoz, R. Bara, R. Elli, A. Paracchi, and G. Faglia, Effect of sulpiride-induced hyperprolactinemia on serum testosterone response to HCG in normal men, J. Clin. Endocrinol. Metab. 43:700, 1976.
G. Magrini, J.R. Ebiner, P. Burekhardt, and J.P. Felber, Study on the relationship between plasma prolactin levels and androgen metabolism in man, J. Clin. Endocrinol. Metab. 43:944, 1976.
M.M. Varma, C.A. Huseman, and J. Johanson, Effect of prolactin on adrenocortical and gonadal function in normal men, J. Clin. Endocrinol. Metab. 44:760, 1977.
L.S. Jacobs, W.B. Mendelson, R.T. Rubin, and J.E. Bauman, Failure of nocturnal prolactin suppression by rnethylsergide to entrain changes in testosterone in normal men, J. Clin. Endocrinol. Metab. 46:561, 1978.
J. Hardy, H. Beauregard, and F. Robert, Prolactin-secreting pituitary adenomas: Transsphenoidal microsurgical treatment, in: Progress in Prolactin Physiology and Pathology (C. Robyn and M. Harter, eds.), pp. 361–370, Elsevier/North Holland, Amsterdam, 1978.
R. Roulier, A. Mattei, A. Reuter, and P. Franchimont, Etude de la prolactine dans les stérilités et les hypogonadismes masculins, Ann. Endocrinol. (Paris) 37:285, 1976.
P. Falaschi, G. Frajese, A. Rocco, G.M. Besser, and L.H. Rees, Prolactin and idiopathic oligospermia, Lancet 1:667, 1979.
K. Saidi, R.V. Wenn, and F. Sharif, Bromocriptine for male infertility, Lancet 1:250, 1977.
S. Segal, W.Z. Polishuk, and M. Ben-David, Hyperprolactinemic male infertility, Fertil. Steril. 27:1425, 1976.
G. Copinschi, M. L’Hermite, R. Leclercq, J. Goldstein, L. Vanhaelst, E. Viragoro, and C. Robyn, Effects of glucocorticoids on pituitary hormonal responses to hypoglycemia: Inhibition of prolactin release, J. Clin. Endocrinol. Metab. 40:442, 1975.
G. Schwinn, A. von zur Muhlen, J. Kubberling, E. Halves, K.W. Wenzel, and H. Meinhold, Plasma prolactin levels after TRH and chlorpromazine in normal subjects and patients with impaired pituitary function, Acta Endocrinol. 79:663, 1975.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Plenum Publishing Corporation
About this chapter
Cite this chapter
Goodman, R.H., Molitch, M.E., Post, K.D., Jackson, I.M.D. (1980). Prolactin-Secreting Adenomas in the Male. In: Post, K.D., Jackson, I.M.D., Reichlin, S. (eds) The Pituitary Adenoma. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3668-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3668-6_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3670-9
Online ISBN: 978-1-4684-3668-6
eBook Packages: Springer Book Archive